Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;66(7):940-4.
doi: 10.1136/ard.2006.066068. Epub 2007 Feb 28.

Changes in causes of death in systemic sclerosis, 1972-2002

Affiliations

Changes in causes of death in systemic sclerosis, 1972-2002

Virginia D Steen et al. Ann Rheum Dis. 2007 Jul.

Abstract

Background: Survival of scleroderma has changed since the renal crisis treatment has become possible.

Aims: To document the changes in survival and organ system causes of mortality in systemic sclerosis (SSc) over the past 25 years in patients from a single medical centre.

Methods: Consecutive patients evaluated at the University of Pittsburgh, Pittsburgh, Pennsylvania, USA between 1 January 1972 and 31 December 1996 were studied. Survival was determined in five 5-year time periods between 1972 and 1997. Causes of death included scleroderma-related (scleroderma renal crisis, pulmonary arterial hypertension, pulmonary fibrosis (PF), gastrointestinal (GI), heart and multiorgan failure) and non-scleroderma-related (cancer, atherosclerotic cardiovascular or cerebrovascular disease, infection, sudden death, other and unknown) causes.

Results: The 10-year survival improved steadily from 54% to 66% during each of the time intervals. There was a significant improvement in survival for patients during 1982-91 compared with those during 1972-81 (p<0.001), even when patients with renal crisis were excluded (p<0.005). The frequency of deaths due to renal crisis significantly decreased over the 30-year time period, from 42% to 6% of scleroderma-related deaths (p<0.001), whereas the proportion of patients with scleroderma who died of PF increased from 6% to 33% (p<0.001). The frequency of pulmonary hypertension, independent of PF, also significantly increased during this time period (p<0.05). There were no changes in scleroderma GI- and heart-related deaths, nor in any of the non-scleroderma-related causes, although patients with scleroderma were less likely to die from scleroderma-related problems in the past 15 years.

Conclusion: The change in the pattern of scleroderma-related deaths over the past 30 years demonstrates that the lung (both pulmonary hypertension and PF) is the primary cause of scleroderma-related deaths today. It is important that aggressive searches continue to develop better therapies for these severe pulmonary complications of SSc.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Steen V D, Medsger T A., Jr Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000432437–2444. - PubMed
    1. Bond C, Pile K D, McNeil J D, Ahern M J, Smith M D, Cleland L G.et al South Australian Scleroderma Register: analysis of deceased patients. Pathology 199830386–390. - PubMed
    1. Bryan C, Knight C, Black C M, Silman A J. Prediction of five‐year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999422660–2665. - PubMed
    1. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G.et al Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 200281139–153. - PubMed
    1. Ioannidis J P, Vlachoyiannopoulos P G, Haidich A B, Medsger T A, Jr, Lucas M, Michet C J.et al Mortality in systemic sclerosis: an international meta‐analysis of individual patient data. Am J Med 20051182–10. - PubMed

Publication types